Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Beelen

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantationM Koldehoff, A H Elmaagacli, N K Steckel, et al.
Der Pathologe|November 19, 2002
[Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study]J Thiele, E Varus, C Wickenhauser, et al.
Experimental Hematology|November 10, 1998
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapyS Kasimir-Bauer, H Ottinger, P Meusers, et al.
Mycoses|January 1, 1990
[Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation]K Quabeck, K D Müller, D W Beelen, et al.
Blood|May 15, 1995
Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcomeD W Beelen, U Graeven, A H Elmaagacli, et al.
Bone Marrow Transplantation|April 21, 2001
Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CMLJ Thiele, H M Kvasnicka, D W Beelen, et al.
Bone Marrow Transplantation|December 1, 1995
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemiaA H Elmaagacli, H W Becks, D W Beelen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptorD W Beelen, H Grosse-Wilde, U Ryschka, et al.
Bone Marrow Transplantation|November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II studyD W Beelen, R Peceny, A Elmaagacli, et al.
Bone Marrow Transplantation|July 13, 2010
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsA H Elmaagacli, N Steckel, M Ditschkowski, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantationM Koldehoff, A H Elmaagacli, N K Steckel, et al.
Der Pathologe|November 19, 2002
[Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study]J Thiele, E Varus, C Wickenhauser, et al.
Experimental Hematology|November 10, 1998
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapyS Kasimir-Bauer, H Ottinger, P Meusers, et al.
Mycoses|January 1, 1990
[Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation]K Quabeck, K D Müller, D W Beelen, et al.
Blood|May 15, 1995
Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcomeD W Beelen, U Graeven, A H Elmaagacli, et al.
Bone Marrow Transplantation|April 21, 2001
Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CMLJ Thiele, H M Kvasnicka, D W Beelen, et al.
Bone Marrow Transplantation|December 1, 1995
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemiaA H Elmaagacli, H W Becks, D W Beelen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptorD W Beelen, H Grosse-Wilde, U Ryschka, et al.
Bone Marrow Transplantation|November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II studyD W Beelen, R Peceny, A Elmaagacli, et al.
Bone Marrow Transplantation|July 13, 2010
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsA H Elmaagacli, N Steckel, M Ditschkowski, et al.
Pageof 10